Oxford Immunotec Global, which sells diagnostic tests for latent Tuberculosis infection, announced terms for its IPO on Friday. The Abingdon, United Kingdom-based company plans to raise $75 million by offering 5.4 million shares at a price range of $13 to $15. At the midpoint of the proposed range, Oxford Immunotec would command a fully diluted market value of $247 million.
Help employers find you! Check out all the jobs and post your resume.
